1989
DOI: 10.1213/00000539-198911000-00019
|View full text |Cite
|
Sign up to set email alerts
|

Esmolol in the Management of Epinephrine-and Cocaine-Induced Cardiovascular Toxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

1991
1991
2014
2014

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…79 -82 The use of the selective ␤ 1 antagonist metoprolol has not been studied in cocaine-associated chest pain, but the short-acting selective ␤ 1 antagonist esmolol resulted in significant increases in blood pressure in up to 25% of patients. 83,84 Although ␤-blocker administration is recommended for patients with MI unrelated to cocaine because it can lead to lower mortality rates, deaths from cocaine-associated MI are exceedingly low, altering the riskbenefit ratio. 47 The ACC/AHA ST-segment-elevation MI guidelines state, "Beta-blockers should not be administered to patients with STEMI precipitated by cocaine use because of the risk of exacerbating coronary spasm" (p E38).…”
Section: ␤-Blockersmentioning
confidence: 99%
“…79 -82 The use of the selective ␤ 1 antagonist metoprolol has not been studied in cocaine-associated chest pain, but the short-acting selective ␤ 1 antagonist esmolol resulted in significant increases in blood pressure in up to 25% of patients. 83,84 Although ␤-blocker administration is recommended for patients with MI unrelated to cocaine because it can lead to lower mortality rates, deaths from cocaine-associated MI are exceedingly low, altering the riskbenefit ratio. 47 The ACC/AHA ST-segment-elevation MI guidelines state, "Beta-blockers should not be administered to patients with STEMI precipitated by cocaine use because of the risk of exacerbating coronary spasm" (p E38).…”
Section: ␤-Blockersmentioning
confidence: 99%
“…For the treatment of severe hypertension, α-adrenergic blockers such as phentolamine are recommended, and β-adrenergic blockers are recommended for the treatment of tachycardia. Esmolol, the short acting β1-selective blocker, is preferred because it has a short half-life; it can be used by volume titration depending on the heart rate; and it can reduce the risk of hypertension and coronary spasm due to the excessive α-stimulation that is found in nonspecific β-blockers [ 13 ]. Calcium-channel blockers, such as verapamil and diltiazem, are also used for hypertension, tachycardia, and arrhythmia.…”
Section: Discussionmentioning
confidence: 99%
“…Propranolol has been used for the control of acute hypertension in cocaine intoxication but may increase hypertension and coronary vasoconstriction because of unopposed ␣ adrenoceptor stimulation 15 . For this reason labetalol 16 , which antagonizes ␣ and ␤ adrenergic receptors, and esmolol 17 , the short-acting ␤1 selective antagonist, may be more appropriate agents to use. Hydralazine controls hypertension but does not restore uterine blood flow 18 .…”
Section: Discussionmentioning
confidence: 99%